Biohaven Ltd (BHVN)
40.69
+0.79
(+1.98%)
USD |
NYSE |
May 03, 16:00
40.68
-0.01
(-0.02%)
After-Hours: 20:00
Biohaven Cash from Operations (Quarterly): -114.88M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -114.88M |
| September 30, 2023 | -94.81M |
| June 30, 2023 | -44.39M |
| March 31, 2023 | -77.64M |
| Date | Value |
|---|---|
| December 31, 2022 | -75.41M |
| September 30, 2022 | -95.56M |
| June 30, 2022 | -67.89M |
| March 31, 2022 | -58.84M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-114.88M
Minimum
Dec 2023
-44.39M
Maximum
Jun 2023
-78.68M
Average
-76.52M
Median
Cash from Operations (Quarterly) Benchmarks
| Amgen Inc | 689.00M |
| Eli Lilly and Co | 1.166B |
| Regeneron Pharmaceuticals Inc | 1.512B |
| Viking Therapeutics Inc | -6.134M |
| Alnylam Pharmaceuticals Inc | -81.52M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -3.914M |
| Cash from Financing (Quarterly) | 245.24M |
| Free Cash Flow | -334.77M |
| Free Cash Flow Per Share (Quarterly) | -1.441 |
| Free Cash Flow Yield | -11.56% |